Edgar Filing: AEROFLEX HOLDING CORP.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended

March 31, 2013

Commission File Number 001-34974

AEROFLEX HOLDING CORP.

(Exact name of Registrant as specified in its Charter)

DELAWARE	01-0899019
(State or other jurisdiction	(I.R.S. Employer
of incorporation or organization)	Identification No.)

35 South Service Road
P.O. Box 6022
Plainview, N.Y.	11803-0622
(Address of principal executive offices)	(Zip Code)

(516) 694-6700

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ¨	Accelerated filer x
Non-accelerated filer ¨	Smaller reporting company ¨
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.

May 9, 2013		84,936,582
(Date)		(Number of Shares)

AEROFLEX HOLDING CORP.

AND SUBSIDIARIES

INDEX

		PAGE
	PART I: FINANCIAL INFORMATION

Item 1	UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
	March 31, 2013 and June 30, 2012	2

	UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
	Three Months Ended March 31, 2013 and 2012	3
	Nine Months Ended March 31, 2013 and 2012	4

	UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
	Three Months Ended March 31, 2013 and 2012	5
	Nine Months Ended March 31, 2013 and 2012	5

	UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
	Nine Months Ended March 31, 2013 and 2012	6

	NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS	7 – 18

Item 2	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
	Three and Nine Months Ended March 31, 2013 and 2012	19 – 30

Item 3	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	31

Item 4	CONTROLS AND PROCEDURES	31

	PART II: OTHER INFORMATION

Item 1	LEGAL PROCEEDINGS	32

Item 1A	RISK FACTORS	32

Item 2	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	32

Item 3	DEFAULTS UPON SENIOR SECURITIES	32

Item 4	MINE SAFETY DISCLOSURES	32

Item 5	OTHER INFORMATION	32

Item 6	EXHIBITS	33

SIGNATURE		34

EXHIBIT INDEX		35

CERTIFICATIONS		36 - 40

Aeroflex Holding Corp. and Subsidiaries

Unaudited Condensed Consolidated Balance Sheets

(In thousands, except share and per share data)

	March 31,			June 30,
	2013			2012
Assets
Current assets:
Cash and cash equivalents	$	34,786		$	41,324
Accounts receivable, less allowance for doubtful accounts of $3,651 and $981		134,087			146,597
Inventories		158,348			158,090
Deferred income taxes		30,957			33,315
Income taxes receivable		437			4,935
Prepaid expenses and other current assets		9,736			11,942
Total current assets		368,351			396,203

Property, plant and equipment, net of accumulated depreciation of $114,338 and $102,310		100,465			101,632
Deferred financing costs, net		13,248			15,720
Other assets		32,266			34,955
Intangible assets with definite lives, net		79,466			119,476
Intangible assets with indefinite lives		112,639			113,461
Goodwill		408,310			408,361

Total assets	$	1,114,745		$	1,189,808

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$	27,591		$	26,822
Advance payments by customers and deferred revenue		22,756			23,433
Income taxes payable		3,365			593
Accrued payroll expenses		19,485			18,635
Accrued expenses and other current liabilities		34,766			37,559
Total current liabilities		107,963			107,042

Long-term debt		606,375			641,375
Deferred income taxes		73,841			94,022
Other long-term liabilities		23,788			20,592
Total liabilities		811,967			863,031

Stockholders' equity:
Preferred stock, par value $.01 per share; 50,000,000 shares authorized, no shares issued and outstanding		-			-
Common stock, par value $.01 per share; 300,000,000 shares authorized, 84,930,387 and 84,845,687 shares issued and outstanding		849			848
Additional paid-in capital		650,988			648,092
Accumulated other comprehensive income (loss)		(43,589	)		(39,476	)
Accumulated deficit		(305,470	)		(282,687	)
Total stockholders' equity		302,778			326,777

Total liabilities and stockholders' equity	$	1,114,745		$	1,189,808

See notes to unaudited condensed consolidated financial statements.

Aeroflex Holding Corp. and Subsidiaries

Unaudited Condensed Consolidated Statements of Operations

(In thousands, except per share data)

	Three Months Ended March 31,
	2013			2012

Net sales	$	160,954		$	162,262
Cost of sales		80,394			83,089
Gross profit		80,560			79,173

Operating expenses:
Selling, general and administrative costs		37,449			38,172
Research and development costs		23,247			22,245
Amortization of acquired intangibles		13,991			15,642
Restructuring charges		396			4,031
Impairment of goodwill and other long-lived assets		-			59,700
ITAR settlement expense		8,000			-
Change in fair value of acquisition contingent consideration liability		-			446
Total operating expenses		83,083			140,236
Operating income (loss)		(2,523	)		(61,063	)

Other income (expense):
Interest expense		(9,448	)		(8,252	)
Write-off of deferred financing costs		-			(864	)
Other income (expense), net		(389	)		(251	)
Total other income (expense), net		(9,837	)		(9,367	)

Income (loss) before income taxes		(12,360	)		(70,430	)
Provision (benefit) for income taxes		(2,971	)		(5,169	)
Net income (loss)	$	(9,389	)	$	(65,261	)

Net income (loss) per common share:
Basic and diluted	$	(0.11	)	$	(0.77	)

Weighted average number of common shares outstanding:
Basic and diluted		84,904			84,824

See notes to unaudited condensed consolidated financial statements.

Aeroflex Holding Corp. and Subsidiaries

Unaudited Condensed Consolidated Statements of Operations

(In thousands, except per share data)

	Nine Months Ended March 31,
	2013			2012

Net sales	$	458,337		$	488,284
Cost of sales		229,880			244,901
Gross profit		228,457			243,383

Operating expenses:
Selling, general and administrative costs		109,769			113,300
Research and development costs		65,213			68,940
Amortization of acquired intangibles		42,634			47,043
Restructuring charges		3,729			5,382
Impairment of goodwill and other long-lived assets		1,340			59,700
ITAR settlement expense		8,000			-
Change in fair value of acquisition contingent consideration liability		-			1,297
Total operating expenses		230,685			295,662
Operating income (loss)		(2,228	)		(52,279	)

Other income (expense):
Interest expense		(29,294	)		(25,386	)
Write-off of deferred financing costs		(824	)		(864	)
Other income (expense), net		(890	)		(944	)
Total other income (expense), net		(31,008	)		(27,194	)

Income (loss) before income taxes		(33,236	)		(79,473	)
Provision (benefit) for income taxes		(10,453	)		(8,635	)
Net income (loss)	$	(22,783	)	$	(70,838	)

Net income (loss) per common share:
Basic and diluted	$	(0.27	)	$	(0.84	)

Weighted average number of common shares outstanding:
Basic and diluted		84,870			84,806

See notes to unaudited condensed consolidated financial statements.

Aeroflex Holding Corp. and Subsidiaries

Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss)

(In thousands)

	Three Months Ended
	March 31,
	2013			2012

Net income (loss)	$	(9,389	)	$	(65,261	)

Other comprehensive income (loss):
Minimum pension liability adjustment, net of tax provision (benefit) of $(230) and $0		(677	)		-
Foreign currency translation adjustment, net of tax provision (benefit) of $(462) and $348		(9,706	)		6,006

Total comprehensive income (loss)	$	(19,772	)	$	(59,255	)

	Nine Months Ended
	March 31,
	2013			2012

Net income (loss)	$	(22,783	)	$	(70,838	)

Other comprehensive income (loss):
Minimum pension liability adjustment, net of tax provision (benefit) of $(230) and $0		(677	)		-
Foreign currency translation adjustment, net of tax provision (benefit) of $(233)and $(18)		(3,436	)		(2,189	)

Total comprehensive income (loss)	$	(26,896	)	$	(73,027	)

See notes to unaudited condensed consolidated financial statements.

Aeroflex Holding Corp. and Subsidiaries

Unaudited Condensed Consolidated Statements of Cash Flows

(In thousands)

	Nine Months Ended March 31,
	2013			2012
Cash flows from operating activities:
Net income (loss)	$	(22,783	)	$	(70,838	)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization		59,880			62,863
Change in fair value of acquisition contingent consideration liability		-			1,297
Impairment of goodwill and other long-lived assets		1,340			59,700
Special accounts receivable reserve		2,529			-
Write-off of deferred financing costs		824			864
Deferred income taxes		(17,291	)		(11,133	)
Share-based compensation		2,610			2,649
Non-cash restructuring charges		-			1,015
Amortization of deferred financing costs		1,648			1,515
Other, net		606			2,063
Change in operating assets and liabilities:
Decrease (increase) in accounts receivable		8,868			38,182
Decrease (increase) in inventories		(2,362	)		5,563
Decrease (increase) in prepaid expenses and other assets		1,758			(7,710	)
Increase (decrease) in accounts payable, accrued expenses and other liabilities		5,473			(31,024	)

Net cash provided by (used in) operating activities		43,100			55,006

Cash flows from investing activities:
Payments for purchase of businesses, net of cash acquired		-			(5,106	)
Proceeds from the sale of building held for sale		1,582			-
Capital expenditures		(14,311	)		(15,030	)
Other, net		572			239

Net cash provided by (used in) investing activities		(12,157	)		(19,897	)

Cash flows from financing activities:
Payment of contingent consideration related to business acquisition		-			(948	)
Debt repayments		(35,000	)		(68,625	)
Deferred financing costs		-			(158	)
Other, net		(641	)		-

Net cash provided by (used in) financing activities		(35,641	)		(69,731	)

Effect of exchange rate changes on cash and cash equivalents		(1,840	)		114

Net increase (decrease) in cash and cash equivalents		(6,538	)		(34,508	)
Cash and cash equivalents at beginning of period		41,324			66,278

Cash and cash equivalents at end of period	$	34,786		$	31,770

See notes to unaudited condensed consolidated financial statements.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. Basis of Presentation

The accompanying unaudited condensed consolidated financial information of Aeroflex Holding Corp. and subsidiaries (“we”, “our”, “us”, or the “Company”) has been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and the rules and regulations of the United States Securities and Exchange Commission (“SEC”), and reflects all adjustments, consisting of normal recurring adjustments, which in management’s opinion are necessary for a fair presentation. The June 30, 2012 balance sheet information has been derived from audited financial statements, but does not include all information or disclosures required by U.S. GAAP.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of sales and expenses during the reporting period. Actual results may differ from those estimates, and such differences may be material to the financial statements.

These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in our annual report on Form 10-K for the fiscal year ended June 30, 2012 (“the fiscal 2012 Form 10-K”).

Unless the context requires otherwise, “fiscal” refers to the twelve months ended June 30 of the applicable year. For example, “fiscal 2012” refers to the twelve months ended June 30, 2012.

Results of operations for interim periods are not necessarily indicative of results to be expected for the full fiscal year or any future periods.

2. Recent Accounting Pronouncements

In June 2011, the Financial Accounting Standards Board (“FASB”) issued authoritative guidance on the presentation of comprehensive income. The new guidance eliminates the option to report other comprehensive income and its components in the statement of stockholders’ equity. Instead, an entity is required to present either a continuous statement of net income and other comprehensive income or two separate but consecutive statements. This new guidance became effective for us beginning with the first quarter of fiscal 2013 and was applied retrospectively. We have presented other comprehensive income in a separate statement immediately following our Statements of Operations. The new guidance would have required entities to present reclassification adjustments out of accumulated other comprehensive income by component in both the statement in which net income is presented and the statement in which other comprehensive income is presented.

In February 2013, the FASB issued guidance which improves the reporting of reclassifications out of accumulated other comprehensive income. The new guidance requires an entity to report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income if the amount being reclassified is required under U.S. GAAP to be reclassified in its entirety to net income. For other amounts that are not required under U.S. GAAP to be reclassified in their entirety from accumulated other comprehensive income to net income in the same reporting period, an entity is required to cross-reference other disclosures required under U.S. GAAP that provide additional detail about those amounts. This new guidance is effective for us in our first quarter of fiscal 2014 with earlier adoption permitted, which should be applied prospectively. We are currently evaluating the impact of our pending adoption of this new guidance on our consolidated financial statements.

In September 2011, the FASB issued authoritative guidance on testing goodwill for impairment. The new guidance provides an entity the option to first perform a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines that this is the case, it is required to perform the currently prescribed two-step goodwill impairment test to identify potential goodwill impairment and measure the amount of goodwill impairment loss to be recognized for that reporting unit (if any). If an entity’s qualitative assessment determines that it is more likely than not that the fair value of a reporting unit exceeds its carrying amount, the two-step goodwill impairment test is not required. This new guidance became effective for us beginning with the first quarter of fiscal 2013. The adoption of this new guidance did not have an impact on our consolidated financial statements.

In July 2012, the FASB issued authoritative guidance allowing entities to use a qualitative approach to test indefinite-lived intangible assets for impairment. The new guidance permits an entity to first perform a qualitative assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying value. If it is concluded that this is the case, it is necessary to perform the currently prescribed quantitative impairment test by comparing the fair value of the indefinite-lived intangible asset with its carrying value. Otherwise, the quantitative impairment test is not required. We adopted this guidance in the first quarter of fiscal 2013. The adoption of the new guidance did not have an impact on our consolidated financial statements.

3. Goodwill, Other Intangible Assets and Other Long Lived Assets

We assess goodwill and other intangible assets with indefinite lives at least annually for impairment, in the fourth quarter of our fiscal year, or more frequently if certain events or circumstances indicate an impairment may have occurred. We test goodwill for impairment at the reporting unit level, which is one level below our operating segments.

The carrying amount of goodwill, by segment, was as follows:

	Microelectronic		Test
	Solutions		Solutions
	("AMS")		("ATS")			Total
	(In thousands)

Balance at June 30, 2012	$	248,090	$	160,271		$	408,361
Foreign currency translation adjustments		950		(1,001	)		(51	)
Balance at March 31, 2013	$	249,040	$	159,270		$	408,310

The components of amortizable intangible assets were as follows:

	March 31, 2013						June 30, 2012
	Gross						Gross
	Carrying		Accumulated		Total Net		Carrying		Accumulated		Total Net
	Amount		Amortization		Book Value		Amount		Amortization		Book Value
	(In thousands)

Developed technology	$	201,601	$	185,613	$	15,988	$	199,489	$	164,065	$	35,424
Customer related intangibles		226,405		165,140		61,265		226,865		146,259		80,606
Non-compete arrangements		10,388		9,110		1,278		10,292		8,007		2,285
Trade names		3,360		2,425		935		3,298		2,137		1,161
Total	$	441,754	$	362,288	$	79,466	$	439,944	$	320,468	$	119,476

In December 2012, based on a reduced forecast in one of our ATS reporting units, Avionics-Communications (Av-Comm), resulting from continued uncertainty in government spending, we tested this reporting unit for impairment. As of December 31, 2012, the Av-Comm group had goodwill of $118.3 million and an enterprise carrying value of $202.3 million. We evaluated if there was impairment by comparing the fair value of the reporting unit with its enterprise carrying value. Based on our December 31, 2012 analysis of the discounted estimated cash flows of this group, we estimated that the fair value of this group was approximately $241 million at December 31, 2012 and that the goodwill had not been impaired. However, should actual results differ from our forecasts of cash flows and our estimated enterprise fair value decreases below the carrying value, then an impairment may occur and we would need to calculate the amount of the write-down of goodwill by comparing the implied fair value of the reporting unit’s goodwill (the excess of the fair value of the reporting unit over the fair value of its net identifiable assets) with the carrying amount of that goodwill. There were no indications of any impairment of the Av-Comm reporting unit at March 31, 2013. We will conduct our annual assessment of goodwill in the fourth quarter.

Based on a reduced forecast of earnings for the fourth quarter of fiscal 2012 in one of our reporting units, the Radio Frequency MicroWave, or RFMW group, we tested this reporting unit for impairment, and as a result we recorded a $56.7 million preliminary non-cash goodwill impairment charge in the third quarter of fiscal 2012. Due to the complexity of the analysis, we finalized this goodwill impairment charge in the fourth quarter of fiscal 2012 with a $1.8 million reduction in this charge resulting in a final impairment of $54.9 million.

As part of the above analysis we also estimated the fair value of the RFMW group tradenames. The carrying value of the tradenames was higher than the fair value determined. Therefore we recorded a preliminary non-cash impairment of $3.0 million in the third quarter of fiscal year 2012 which we finalized in the fourth quarter of fiscal 2012 by reducing this impairment charge by $2.3 million to $700,000.

Other Long Lived Assets

In December 2010, in connection with our consolidation of certain manufacturing operations in our AMS segment, we recorded a $4.9 million impairment charge to restructuring expense based on the then fair value of our Whippany, New Jersey facility. The net proceeds from the sale of the Whippany building in January 2013 were less than its adjusted carrying value. Therefore, in December 2012 we recorded a further $1.3 million impairment to the building.

4. Restructuring Charges

The following table sets forth the charges and payments related to the restructuring liability, which is reflected in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheets, and primarily relates to the reorganization of our ATS Wireless business, for the period indicated:

	Balance									Balance
	June 30,									March 31,
	2012		Nine Months Ended March 31, 2013							2013
								Effect of
	Restructuring				Cash			Foreign		Restructuring
	Liability		Net Additions		Payments			Currency		Liability
			(In thousands)

Severance costs	$	2,085	$	2,916	$	(4,954	)	$	55	$	102

Facilities closure costs		502		813		(1,184	)		1		132

Total	$	2,587	$	3,729	$	(6,138	)	$	56	$	234

5. Accounts Receivable Reserve

In the third quarter of 2013, we recorded a special reserve of $2.5 million for all accounts receivable due from a customer whose bank accounts were seized by the U.S. Attorney. This charge is included in selling, general and administrative expenses in the accompanying statement of operations.

6. Inventories

Inventories consisted of the following:

	March 31,		June 30,
	2013		2012
	(In thousands)

Raw materials	$	77,471	$	82,202
Work in process		55,169		45,067
Finished goods		25,708		30,821
	$	158,348	$	158,090

7. Derivative Financial Instruments

We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. When deemed appropriate to do so, we enter into interest rate swap derivatives to manage the effects of interest rate movements on portions of our debt. We routinely enter into foreign currency forward contracts, not designated as hedging instruments, to protect us from fluctuations in exchange rates.

Foreign Currency Contract Derivatives

Foreign currency contracts are used to protect us from fluctuations in exchange rates. Our foreign currency contracts are not designated as hedges and therefore the change in fair value is included in other income (expense) as it occurs. As of March 31, 2013, we had $38.5 million of notional value foreign currency forward contracts maturing through April 30, 2013. Notional amounts do not quantify risk or represent assets or liabilities of the Company, but are used in the calculation of cash settlements under the contracts.

The fair values of our derivative financial instruments included in the consolidated balance sheets as of March 31, 2013 and June 30, 2012 were as follows:

Asset (Liability) Derivatives

March 31, 2013

June 30, 2012

Balance Sheet

Location

Fair Value ⁽¹⁾

Location

Fair Value ⁽¹⁾

(In thousands)

Derivatives not designated as hedging instruments:

Foreign currency forward contracts

Prepaid expenses and other current assets

184

Prepaid expenses and other current assets

⁽¹⁾

The fair values of derivative assets and liabilities are determined based on observable market data and are considered level 2 in the fair value hierarchy.

The amounts of the gains and losses related to our derivative financial instruments not designated as hedging instruments for the three and nine months ended March 31, 2013 and 2012 were as follows:

Derivatives Not	Location of Gain or (Loss)	Amount of Gain or (Loss)
Designated as	Recognized in Earnings on	Recognized in Earnings on
Hedging Instruments	Derivatives	Derivatives
		Three Months Ended				Nine Months Ended
		March 31,				March 31,
		2013		2012		2013		2012
		(In thousands)
Foreign currency forward contracts	Other income (expense)	$	190	$	522	$	161	$	335

8. Long Term Debt and Credit Agreements

On May 24, 2012, we amended our senior secured credit facility to increase the flexibility under the total leverage ratio covenant. As a result of the amendment, the applicable LIBOR interest margin increased from 300 basis points to 450 basis points.

For the nine months ended March 31, 2013, we voluntarily prepaid $35.0 million of our term loan with cash on hand from operations. The voluntary prepayment resulted in the write-off of the related deferred financing costs of $824,000. As a result of prepayments made to date, there are no required debt principal payments due until fiscal 2018.

As of March 31, 2013, we were in compliance with all of the financial covenants contained in the senior secured credit facility.

Interest paid was $27.6 million and $23.8 million for the nine months ended March 31, 2013 and 2012, respectively. Accrued interest of $4.7 million and $5.1 million was included in accrued expenses and other current liabilities at March 31, 2013 and June 30, 2012, respectively.

The fair value of our debt instruments was as follows:

	As of March 31, 2013
	Carrying Amount		Estimated Fair Value
	(In thousands)

Senior secured term loan facility	$	606,375	$	616,987

As of June 30, 2012, our total debt had a carrying value of $641.4 million and a fair value of $622.1 million.

The estimated fair values of our debt instruments were based on quoted prices and are considered Level 2 measurements. Fair value estimates related to our debt instruments are made at a specific point in time based on relevant market information. The estimates are subjective in nature and involve uncertainties and matters of significant judgments and therefore cannot be determined with precision. Changes in assumptions could significantly affect these estimates.

9. Share-Based Payment Arrangements

In November 2011, our stockholders approved the 2011 Omnibus Incentive Plan, or the 2011 Plan. The 2011 Plan authorizes us to provide equity-based compensation in the form of options, stock appreciation rights, restricted stock and restricted stock units, or RSUs, performance restricted stock units, or PRSUs, other share based awards and performance awards. Awards may be granted to employees, directors and consultants of the Company. The number of shares of our common stock authorized for award under the 2011 Plan was 4.5 million shares. The compensation committee of our board of directors administers the 2011 Plan including selecting participants, the type and terms of awards to be granted and number of shares subject to the awards. As of March 31, 2013, 2.1 million shares of our common stock remain available for grants pursuant to the 2011 Plan.

Restricted Stock Units

During the nine months ended March 31, 2013, the compensation committee awarded RSUs covering a total of 1.0 million shares. RSUs generally vest in equal tranches over a service period of up to three years. We have elected to recognize compensation cost on a straight-line basis over the requisite service period for the entire award. The estimated fair value of RSUs granted under the 2011 Plan was determined based on the fair value of our common stock on the date of grant. RSUs awarded to employees in certain foreign countries, covering 54,000 shares, are to be settled in cash at their vesting date, and were therefore recorded as liability-classified awards. Liability-classified awards are remeasured to fair value at each reporting date until settlement.

As of March 31, 2013, the total unrecognized compensation cost related to RSUs was $7.5 million and the related weighted average period over which it is expected to be recognized was approximately 2.4 years.

Additional information with respect to our RSUs was as follows:

						Weighted
						Average
						Grant Date
				Aggregate		Fair Value
	Shares			Intrinsic Value		Per Share
	(In thousands)			(In thousands)

Nonvested at June 30, 2012		371
Granted		943
Vested (includes 30,389 units withheld for income taxes)		(105	)
Forfeited		(60	)

Nonvested at March 31, 2013		1,149		$	9,030	$	7.12

Expected to vest at March 31, 2013		1,077		$	8,465	$	7.12

Performance Restricted Stock Units

During the nine months ended March 31, 2013, the compensation committee awarded PRSUs covering a total of 733,000 shares. PRSUs include both a service condition and a performance condition. The number of PRSUs that will vest is based on the Company achieving pre-established annual financial performance targets. The PRSUs generally have a service period of up to three years. Vesting of 0% to 150% of the indicated shares may occur depending on the extent to which targets are achieved. We have elected to recognize compensation cost on a straight-line basis over the requisite service period for the entire award. The estimated fair value of PRSUs granted under the 2011 Plan was determined based on the fair value of our common stock on the date of grant.

As of March 31, 2013, the total unrecognized compensation cost related to PRSUs was $3.3 million and the related weighted average period over which it is expected to be recognized was approximately 2.4 years.

Additional information with respect to our PRSUs was as follows:

						Weighted
						Average
						Grant Date
				Aggregate		Fair Value
	Shares			Intrinsic Value		Per Share
	(In thousands)			(In thousands)

Nonvested at June 30, 2012		-
Granted		733
Changes in units based on anticipated performance		(171	)
Forfeited		(4	)

Nonvested at March 31, 2013		558		$	4,412	$	6.74

Expected to vest at March 31, 2013		545		$	4,282	$	6.74

Membership Interest in Parent LLC

On August 15, 2007 certain members of our management were granted Class B membership interests and during the years ended June 30, 2011 and 2010 certain employees were granted Class B-1 membership interests in a limited liability company (parent LLC) that owns 76.5% of our common stock as of March 31, 2013. The parent LLC is a holding company with no operations or employees of its own. The parent LLC has three classes of membership interests, Class A, Class B and Class B-1. Our non-management equity investors, or their affiliates, and certain of our employees that made equity investments in parent LLC are Class A members. Class B and Class B-1 members consist of certain of our employees.

Compensation expense attributable to share-based compensation (for RSUs, PRSUs and membership interests) was $2.6 million ($1.6 million after tax) for the nine months ended March 31, 2013 and $2.6 million ($1.6 million after tax) for the nine months ended March 31, 2012.

10. Net Income (Loss) Per Common Share

Our consolidated statements of operations present basic and diluted net income (loss) per common share. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted net income (loss) per common share reflects the dilutive effects of RSUs and PRSUs, if any. The treasury stock method was used to determine the dilutive effect of these potentially dilutive securities. Due to the net loss for the three and nine months ended March 31, 2013 and 2012, all shares of common stock equivalents were excluded from diluted net income (loss) per common share because they were anti-dilutive.

11. Accumulated Other Comprehensive Income (Loss)

Accumulated other comprehensive income (loss) was as follows:

	As of and for the
	Nine Months Ended March 31,
	2013			2012
	(In thousands)

Net minimum pension liability, beginning of year	$	(1,448	)	$	(544	)
Nine months' activity in minimum pension liability, net of tax		(677	)		-
Net minimum pension liability, March 31		(2,125	)		(544	)

Net cumulative translation adjustment, beginning of year		(38,028	)		(31,992	)
Nine months' activity in cumulative translation adjustment, net of tax		(3,436	)		(2,189	)
Net cumulative translation adjustment, March 31		(41,464	)		(34,181	)

Accumulated other comprehensive income (loss)	$	(43,589	)	$	(34,725	)

12. Income Taxes

The income tax benefit was $3.0 million and $5.2 million for the three months ended March 31, 2013 and 2012 on a pre-tax loss of $12.4 million and $70.4 million, respectively. The income tax benefit for the three months ended March 31, 2013 reflects a net discrete benefit of $190,000 primarily related to the retroactive extension of the research credit in the United States. The income tax benefit for the three months ended March 31, 2012 reflects a discrete benefit of $1.9 million of which $1.6 million relates to previously unanticipated tax benefits taken on our prior year tax returns in the United States and United Kingdom and a $606,000 tax benefit due to a change in reporting for the state of Colorado, partially offset by a prior year non-trade loss in the U.K. of $324,000 for which future utilization is uncertain.

We recorded an income tax benefit for the nine months ended March 31, 2013 and 2012 of $10.5 million and $8.6 million on a pre-tax loss of $33.2 million and $79.5 million, respectively. The income tax benefit for the nine months ended March 31, 2013 reflects a discrete benefit of $442,000 relating to statutory income tax rate reductions in the U.K. and Sweden and the retroactive extension of the U.S. research credit largely offset by an adjustment of estimated deferred taxes. The income tax benefit for the nine months ended March 31, 2012 reflects a discrete benefit of $2.6 million of which $1.6 million relates to previously unanticipated tax benefits taken on our prior year tax returns in the United States and United Kingdom, a $606,000 tax benefit due to a change in reporting for the state of Colorado and a benefit of $700,000 relating to a reduction in the statutory income tax rate in the U.K., partially offset by a prior year non-trade loss in the U.K. of $324,000 for which future utilization is uncertain.

The effective income tax rate for all periods differed from the amount computed by applying the U.S. federal income tax rate to income (loss) before taxes primarily due to foreign, state and local income taxes, including U.S. income tax on certain foreign net income that we anticipate will be repatriated to the U.S. and a goodwill and intangible impairment charge that was mostly non-deductible during the three and nine months ended March 31, 2012.

Absent the discrete items, the effective tax rates were 23% and 5% for the three months ended March 31, 2013 and 2012 and 30% and 8% for the nine months ended March 31, 2013 and 2012, respectively. The provision for the three and nine months ended March 31, 2013 was a combination of year-to-date U.S. tax benefit on a domestic book loss and foreign tax expense on foreign book income. The provision for the three and nine months ended March 31, 2012 was a combination of U.S. tax benefit on domestic book losses and foreign tax benefit on foreign book losses. The prior year’s effective tax rates were impacted by the aforementioned impairment charges.

In the nine months ended March 31, 2013 and 2012, we paid income taxes of $5.1 million and $7.6 million and received refunds of $5.7 million and $184,000, respectively.

13. Legal Matters

We have identified instances of noncompliance with the International Traffic in Arms Regulations, or ITAR, in certain of our past business activities as well as in the pre-acquisition business activities of certain acquired companies. These include the inadvertent misclassification and/or export of products without the required license and the disclosure of controlled technology to certain foreign national employees. These matters were formally disclosed to the U.S. Department of State from time to time from fiscal 2007 and virtually all have been resolved without penalty. However, to resolve a Proposed Charging Letter that references those outstanding ITAR violations that were disclosed voluntarily to the State Department initially in 2007 and have been pending since 2008 concerning space related hardware items that were exported to China and, without the requisite State Department licenses, to end users in numerous other foreign countries, we are in the process of finalizing the terms of a Consent Agreement, proposed initially by the U.S. Department of State, Office of Defense Trade Controls Compliance (“DTCC”) at a meeting in February, 2013, that would involve, among other things, a fine of $8.0 million payable over a two year period, $4.0 million of which would be suspended and eligible for credit based on qualified compliance expenditures and investments made by the Company. During the quarter ended March 31, 2013, we recorded a charge of $8.0 million representing the legal obligation to the DTCC under the proposed terms of the Consent Agreement. The qualified compliance expenditures are subject to the approval of the DTCC. Going forward, the resolution of this issue will not impact our ability to transact business internationally.

In March 2005, we sold the net assets of our shock and vibration control device manufacturing business, which we refer to as VMC. Under the terms of the sale agreements, we retained certain liabilities relating to adverse environmental conditions that existed at the premises occupied by VMC as of the date of sale. We recorded a liability for the estimated remediation costs related to adverse environmental conditions that existed at the VMC premises when it was sold. The accrued environmental liability at March 31, 2013 was $1.1 million, of which $352,000 is expected to be paid within one year.

We are also involved in various other claims and legal actions that arise in the ordinary course of business. We do not believe that the ultimate resolution of any of these actions will have a material adverse effect on our business, results of operations, financial position, liquidity or capital resources.

14. Business Segments

We are a global provider of radio frequency, or RF, and microwave integrated circuits, components and systems used in the design, development and maintenance of technically demanding, high-performance wireless communication systems. Our solutions include highly specialized microelectronic components and test and measurement equipment used by companies in the space, avionics, defense, commercial wireless communications, medical and other markets. Approximately 28% and 33% of our sales for the three months ended March 31, 2013 and 2012 and 28% and 35% for the nine months ended March 31, 2013 and 2012, respectively, were to agencies of the United States government or to prime defense contractors or subcontractors of the United States government. No customer constituted more than 10% of sales during any of the periods presented. Inter-segment sales were not material and have been eliminated from the tables below.

The majority of our operations are located in the United States. We also have operations in Europe and Asia, with our most significant non-U.S. operations in the U.K. Net sales from facilities located in the U.K. were $43.5 million and $29.7 million for the three months ended March 31, 2013 and 2012 and $116.9 million and $98.6 million for the nine months ended March 31, 2013 and 2012, respectively. Total assets of the U.K. operations were $167.4 million as of March 31, 2013 and $177.9 million as of June 30, 2012.

Net sales, based on the customers’ locations, attributed to the United States and other regions were as follows:

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
	2013		2012		2013		2012
	(In thousands)

United States of America	$	82,563	$	102,341	$	244,976	$	296,917
Europe and Middle East		38,687		34,383		104,703		98,673
Asia and Australia		34,514		22,298		92,763		79,026
Other regions		5,190		3,240		15,895		13,668
	$	160,954	$	162,262	$	458,337	$	488,284

We organize our operations into two segments: Aeroflex Microelectronic Solutions, or AMS, and Aeroflex Test Solutions, or ATS. We engineer, manufacture and market a diverse range of products in each of our segments.

AMS offers a broad range of microelectronics products and is a leading provider of high-performance, high reliability specialty microelectronics components. Its products include high reliability, or HiRel, microelectronics/semiconductors, RF and microwave components, mixed-signal/digital Application Specific Integrated Circuits (“ASICs”) and motion control products. ATS is a leading provider of a broad line of specialized test and measurement equipment. Its products include wireless test equipment, military radio and private mobile radio test equipment, avionics test equipment, synthetic test equipment and general purpose test equipment.

Selected financial data by segment was as follows:

	Three Months Ended						Nine Months Ended
	March 31,						March 31,
	2013			2012			2013			2012
	(In thousands)
Net sales
- Microelectronic solutions ("AMS")	$	85,662		$	91,288		$	238,663		$	257,685
- Test solutions ("ATS")		75,292			70,974			219,674			230,599
Net sales	$	160,954		$	162,262		$	458,337		$	488,284

Segment adjusted operating income
- AMS	$	19,233		$	22,925		$	52,459		$	61,615
- ATS		6,974			(456	)		16,987			11,768
- Corporate expense		(2,558	)		(2,723	)		(10,067	)		(9,366	)
Adjusted operating income		23,649			19,746			59,379			64,017

Amortization of acquired intangibles
- AMS		(8,845	)		(9,013	)		(26,517	)		(27,059	)
- ATS		(5,146	)		(6,629	)		(16,117	)		(19,984	)
Restructuring charges
- AMS		(26	)		(177	)		(45	)		(788	)
- ATS		(301	)		(3,854	)		(3,615	)		(4,594	)
- Corporate		(69	)		-			(69	)		-
Impairment of goodwill and other long-lived assets - AMS		-			(59,700	)		(1,340	)		(59,700	)
ITAR settlement expense - AMS		(8,000	)		-			(8,000	)		-
Increase in fair value of acquisition contingent consideration liability - Corporate		-			(446	)		-			(1,297	)
Share-based compensation
- AMS		(291	)		(134	)		(667	)		(190	)
- ATS		(324	)		(77	)		(543	)		(111	)
- Corporate		(628	)		(708	)		(1,400	)		(2,348	)
Special accounts receivable reserve - AMS		(2,529	)		-			(2,529	)		-
Business acquisition and divestiture related costs - Corporate		-			-			(697	)		(14	)
Current period impact of acquisition related adjustments
- AMS		20			(38	)		31			(113	)
- ATS		22			22			66			67
- Corporate		(55	)		(55	)		(165	)		(165	)
Operating income (GAAP)		(2,523	)		(61,063	)		(2,228	)		(52,279	)

Interest expense		(9,448	)		(8,252	)		(29,294	)		(25,386	)
Write-off of deferred financing costs		-			(864	)		(824	)		(864	)
Other income (expense), net		(389	)		(251	)		(890	)		(944	)
Income (loss) before income taxes	$	(12,360	)	$	(70,430	)	$	(33,236	)	$	(79,473	)

Management evaluates the operating results of our two segments based upon adjusted operating income, which is pre-tax operating income before certain non-cash, non-recurring and other items. We have set out above our adjusted operating income by segment and in the aggregate, and have provided a reconciliation of adjusted operating income to operating income on a GAAP basis and income (loss) before income taxes for the periods presented.

Among the adjustment items in the quarter and nine months ended March 31, 2013 are (i) a regulatory settlement of $8.0 million recorded in connection with outstanding ITAR violations and (ii) a reserve of $2.5 million against accounts receivable due from a customer whose bank accounts were recently seized by the U.S. Attorney (see Note 5).

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Unless the context requires otherwise, (i) “we”, “our”, “us”, or the “Company” refer to Aeroflex Holding Corp. and subsidiaries and (ii) “fiscal” refers to the twelve months ended June 30 of the applicable year. For example, “fiscal 2012” refers to the twelve months ended June 30, 2012.

Forward-Looking Statements

This report contains "forward-looking statements". All statements other than statements of historical fact are "forward-looking" statements for purposes of the U.S. federal and state securities laws. These statements may be identified by the use of forward-looking terminology such as "anticipate", "believe", "continue", "could", "estimate", "expect", "intend", "may", "might", "plan", "potential", "predict", "should" or "will" or the negative thereof or other variations thereon or comparable terminology.

We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors may cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. A listing of some of the key factors that could cause actual results to differ from our expectations is included under the caption “Risk Factors” in our fiscal 2012 Form 10-K.

Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included in this report are made only as of the date hereof. We undertake no obligation to update or revise any forward-looking statements, either to reflect new developments, or for any other reason, except as required by law.

Overview

Company Background

We are a leading global provider of RF and microwave integrated circuits, components and systems used in the design, development and maintenance of technically demanding, high-performance wireless communication systems. Our solutions include highly specialized microelectronic components and test and measurement equipment used by companies in the (i) space, avionics, defense; (ii) commercial wireless communications; and (iii) medical and other markets. We have targeted customers in these end markets because we believe our solutions address their technically demanding requirements. We were founded in 1937 and have proprietary technology that is based on extensive know-how and a long history of research and development focused on specialized technologies, often in collaboration with our customers.

Business Segments

Our business segments and major products included in each segment are as follows:

Aeroflex Microelectronic Solutions (“AMS”)

HiRel microelectronics/semiconductors

RF and microwave components

Mixed-signal/digital ASICs

Motion control products

Aeroflex Test Solutions (“ATS”)

Wireless test equipment

Military radio and Private Mobile Radio, or PMR, test equipment

Avionics test equipment

Synthetic test equipment

General purpose test equipment

Results of Operations

The following table sets forth our historical results of operations as a percentage of net sales for the periods indicated below:

	Three Months Ended						Nine Months Ended
	March 31,						March 31,
	2013			2012			2013			2012
Net sales		100.0	%		100.0	%		100.0	%		100.0	%
Cost of sales		49.9			51.2			50.2			50.2
Gross profit		50.1			48.8			49.8			49.8

Operating expenses:
Selling, general and administrative costs		23.3			23.5			23.9			23.2
Research and development costs		14.4			13.7			14.2			14.1
Amortization of acquired intangibles		8.7			9.6			9.3			9.6
Restructuring charges		0.2			2.5			0.8			1.1
Impairment of goodwill and other long-lived assets		-			36.8			0.3			12.2
ITAR settlement expense		5.0			-			1.7			-
Change in fair value of acquisition contingent
consideration liability		-			0.3			-			0.3
Total operating expenses		51.6			86.4			50.2			60.5

Operating income		(1.5	)		(37.6	)		(0.4	)		(10.7	)

Other income (expense):
Interest expense		(5.9	)		(5.1	)		(6.4	)		(5.2	)
Write-off of deferred financing costs		-			(0.5	)		(0.2	)		(0.2	)
Other income (expense), net		(0.2	)		(0.2	)		(0.2	)		(0.2	)

Income (loss) before income taxes		(7.6	)		(43.4	)		(7.2	)		(16.3	)
Provision (benefit) for income taxes		(1.8	)		(3.2	)		(2.3	)		(1.8	)

Net income (loss)		(5.8	)%		(40.2	)%		(4.9	)%		(14.5	)%

Three Months Ended March 31, 2013 Compared to Three Months Ended March 31, 2012

The end markets in which we operate continue to be challenged by worldwide economic factors, including the uncertainty over U.S. government spending, which has caused customers to be more conservative with their buying patterns.

Our experienced senior management team constantly reviews the Company’s operations, continually looks for additional efficiencies and takes actions needed to improve the Company’s profitability based on our current level of business. For instance, during fiscal 2012 we initiated cost saving measures by reducing personnel at various locations worldwide. These activities continued throughout fiscal 2013, primarily with the reorganization of our European ATS business to make their operations more focused and appropriate for the sales level that we are currently experiencing, as well as positioning us for the opportunity to achieve future growth. We are also investigating plans to consolidate our domestic ATS Avionics-Communications business.

Net Sales. Net sales decreased $1.3 million, or 1%, to $161.0 million for the three months ended March 31, 2013 from $162.3 million for the three months ended March 31, 2012.

Net Sales
Three Months			% of					% of
Ended			Consolidated					Consolidated
March 31,	AMS		Net Sales			ATS		Net Sales			Total
(In thousands, except percentages)

2013	$	85,662		53.2	%	$	75,292		46.8	%	$	160,954
2012	$	91,288		56.3	%	$	70,974		43.7	%	$	162,262

Net sales in the AMS segment decreased $5.6 million, or 6%, to $85.7 million for the three months ended March 31, 2013 from $91.3 million for the three months ended March 31, 2012. This sales decrease was primarily attributable to a volume driven reduction of $5.6 million of HiRel microelectronics/semiconductors primarily resulting from reduced government spending on defense and space related programs.

Net sales in the ATS segment increased $4.3 million, or 6%, to $75.3 million for the three months ended March 31, 2013 from $71.0 million for the three months ended March 31, 2012. The increase is primarily related to an increase in wireless test product sales of $11.1 million, partially offset by volume driven reductions in various product lines primarily due to reduced government spending.

Gross Profit. Gross profit equals net sales less cost of sales. Cost of sales includes materials, direct labor, amortization of capitalized software development costs and overhead expenses such as engineering labor, fringe benefits, depreciation, allocable occupancy costs and manufacturing supplies.

On a consolidated basis, gross profit was $80.6 million, or 50.1% of net sales, for the three months ended March 31, 2013 compared to $79.2 million, or 48.8% of net sales, for the three months ended March 31, 2012.

Gross Profit
Three Months			% of					% of					% of
Ended			Net					Net					Net
March 31,	AMS		Sales			ATS		Sales			Total		Sales
(In thousands, except percentages)

2013	$	41,733		48.7	%	$	38,827		51.6	%	$	80,560		50.1	%
2012	$	46,363		50.8	%	$	32,810		46.2	%	$	79,173		48.8	%

Gross margins in the AMS segment were 48.7% for the three months ended March 31, 2013 and 50.8% for the three months ended March 31, 2012. Gross profit decreased $4.6 million for the three months ended March 31, 2013 as compared to the three months ended March 31, 2012 due to the reduction in sales and product mix. The decrease in gross margin was principally attributable to product mix, as the decreased sales of HiRel microelectronics standard products carried a higher gross margin than the segment average.

Gross margins in the ATS segment were 51.6% for the three months ended March 31, 2013 and 46.2% for the three months ended March 31, 2012. Gross profit increased $6.0 million for the three months ended March 31, 2013 as compared to the three months ended March 31, 2012 due to product mix and the increase in sales. The gross margin increased primarily due to product mix, as the increased wireless test product sales carried a higher gross margin than the segment average and the decreased sales of radio test sets carried a lower gross margin than the segment average.

Selling, General and Administrative Costs. Selling, general and administrative (“SG&A”) costs include office and management salaries, fringe benefits, commissions, insurance and professional fees.

On a consolidated basis, SG&A costs decreased $723,000, or 2%, to $37.4 million for the three months ended March 31, 2013 from the three months ended March 31, 2012. Excluding the reserve of $2.5 million in the AMS segment discussion below, SG&A costs decreased $3.2 million, or 8%, to 21.8% of net sales, primarily due to a reduction in various expenses as a result of our implementation of cost saving measures.

Selling, General and Administrative Costs
Three Months			% of					% of							% of
Ended			Net					Net							Net
March 31,	AMS		Sales			ATS		Sales			Corporate		Total		Sales
(In thousands, except percentages)

2013	$	15,349		17.9	%	$	18,859		25.0	%	$	3,241	$	37,449		23.3	%
2012	$	13,850		15.2	%	$	20,836		29.4	%	$	3,486	$	38,172		23.5	%

In the AMS segment, SG&A costs increased $1.5 million, or 10%, to $15.3 million for the three months ended March 31, 2013 from the three months ended March 31, 2012. This increase was primarily attributable to a reserve of $2.5 million established for accounts receivables with a customer whose bank accounts were seized by the U.S. Attorney. Excluding the reserve of $2.5 million, SG&A costs in the AMS segment decreased $1.0 million, to 15.0% of net sales, primarily due to a reduction in various expenses as a result of our implementation of cost saving measures.

In the ATS segment, SG&A costs decreased $2.0 million, or 9%, to $18.9 million for the three months ended March 31, 2013 from the three months ended March 31, 2012 primarily related to cost saving measures taken, which reduced personnel at various locations worldwide. As a percentage of sales, SG&A costs in the ATS segment decreased to 25.0% from 29.4% for the three months ended March 31, 2013 from the three months ended March 31, 2012 due to the reduction in expenses, coupled with an increase in sales.

Research and Development Costs. Research and development costs include materials, engineering labor and allocated overhead.

On a consolidated basis, research and development costs increased $1.0 million, or 5%, for the three months ended March 31, 2013 from the three months ended March 31, 2012.

Research and Development Costs
Three Months			% of					% of					% of
Ended			Net					Net					Net
March 31,	AMS		Sales			ATS		Sales			Total		Sales
(In thousands, except percentages)

2013	$	9,951		11.6	%	$	13,296		17.7	%	$	23,247		14.4	%
2012	$	9,758		10.7	%	$	12,487		17.6	%	$	22,245		13.7	%

Restructuring Charges. On a consolidated basis, restructuring charges were $396,000 for the three months ended March 31, 2013 compared to $4.0 million for the three months ended March 31, 2012. The restructuring charges in both periods were primarily related to cost savings initiatives which resulted in reductions in personnel at various locations worldwide.

Impairment of Goodwill and Other Long-Lived Assets. In the third quarter of fiscal 2012, due to a decline in the RFMW reporting unit’s forecasted operating results for the fourth quarter of fiscal 2012 and beyond, we recorded preliminary non-cash impairment charges to both goodwill and tradenames related to the RFMW reporting unit of $56.7 million and $3.0 million, respectively. There were no similar impairment charges recorded in the three months ended March 31, 2013.

ITAR Settlement Expense. In order to resolve a Proposed Charging Letter that references certain outstanding ITAR violations that were disclosed voluntarily to the State Department, we are in the process of finalizing the terms of a Consent Agreement, that would involve, among other things, a fine of $8.0 million payable over a two year period, $4.0 million of which would be suspended and eligible for credit based on qualified compliance expenditures and investments made by the Company. During the quarter ended March 31, 2013, we recorded a charge of $8.0 million representing the legal obligation to the U.S. Department of State, Office of Defense Trade Controls Compliance (“DTCC”) under the proposed terms of the Consent Agreement. The qualified compliance expenditures are subject to the approval of the DTCC. Going forward, the resolution of this issue will not impact our ability to transact business internationally.

Interest Expense. Interest expense was $9.4 million for the three months ended March 31, 2013 and $8.3 million for the three months ended March 31, 2012. Interest expense increased as a result of the 150 basis point increase in our interest rate effective May 24, 2012, in connection with the amendment of our senior secured credit facility, partially offset by a lower outstanding principal amount due to voluntary debt payments of $50.0 million in the twelve months ended March 31, 2013.

Income Taxes. The income tax benefit was $3.0 million for the three months ended March 31, 2013 on a pre-tax loss of $12.4 million. We recorded an income tax benefit for the three months ended March 31, 2012 of $5.2 million on a pre-tax loss of $70.4 million. The effective income tax rate for both periods differed from the U.S. statutory rate primarily due to foreign, state and local income taxes, including U.S. income tax on certain foreign net income that we anticipate will be repatriated to the U.S. and, for the three months ended March 31, 2012, the mostly non-deductible goodwill and intangible impairment charge of $59.7 million.

The income tax benefit for the three months ended March 31, 2013 reflects a net discrete benefit of $190,000 primarily related to the retroactive extension of the research credit in the United States. The income tax benefit for the three months ended March 31, 2012 reflects a discrete benefit of $1.9 million of which $1.6 million relates to previously unanticipated tax benefits taken on our prior year tax returns in the United States and United Kingdom and a $606,000 tax benefit due to a change in reporting for the state of Colorado, partially offset by a prior year non-trade loss in the U.K. of $324,000 for which future utilization is uncertain.

Absent the discrete items, the effective tax rates were 23% and 5% for the three months ended March 31, 2013 and 2012, respectively. The current year’s provision was a combination of year-to-date U.S. tax benefit on a domestic book loss and foreign tax expense on foreign book income. The prior year’s provision was a combination of U.S. tax benefit on domestic book losses and foreign tax benefit on foreign book losses. The prior year’s effective tax rate was impacted by the aforementioned impairment charge.

In the three months ended March 31, 2013 and 2012, we paid income taxes of $3.5 million and $1.3 million and received refunds of $255,000 and $4,000, respectively, related to federal, state and foreign income taxes.

Net Income (Loss). Net income (loss) was $(9.4) million for the three months ended March 31, 2013 and $(65.3) million for the three months ended March 31, 2012.

Nine Months Ended March 31, 2013 Compared to Nine Months Ended March 31, 2012

Net Sales. Net sales decreased $29.9 million, or 6%, to $458.3 million for the nine months ended March 31, 2013 from $488.3 million for the nine months ended March 31, 2012.

Net Sales
Nine Months			% of					% of
Ended			Consolidated					Consolidated
March 31,	AMS		Net Sales			ATS		Net Sales			Total
(In thousands, except percentages)

2013	$	238,663		52.1	%	$	219,674		47.9	%	$	458,337
2012	$	257,685		52.8	%	$	230,599		47.2	%	$	488,284

Net sales in the AMS segment decreased $19.0 million, or 7%, to $238.7 million for the nine months ended March 31, 2013 from $257.7 million for the nine months ended March 31, 2012. This sales decrease was primarily attributable to a volume driven reduction of $17.9 million of HiRel microelectronics/semiconductors, of which $4.9 million relates to sales to a long standing customer whose bank accounts were seized by the U.S. Attorney; the balance relates to reduced government spending on defense and space programs.

Net sales in the ATS segment decreased $10.9 million, or 5%, to $219.7 million for the nine months ended March 31, 2013 from $230.6 million for the nine months ended March 31, 2012. The decrease was primarily attributable to volume driven reductions of $9.7 million in radio test sets primarily related to a reduction in GRMATS sales to the U.S. Military; and $6.1 million in avionics test equipment; along with volume driven reductions in various other product lines primarily due to reduced government spending. These reductions in sales were partially offset by an increase in wireless test product sales of $10.6 million.

Gross Profit. On a consolidated basis, gross profit was $228.5 million, or 49.8% of net sales, for the nine months ended March 31, 2013 compared to $243.4 million, or 49.8% of net sales, for the nine months ended March 31, 2012.

Gross Profit
Nine Months			% of					% of					% of
Ended			Net					Net					Net
March 31,	AMS		Sales			ATS		Sales			Total		Sales
(In thousands, except percentages)

2013	$	116,803		48.9	%	$	111,654		50.8	%	$	228,457		49.8	%
2012	$	129,665		50.3	%	$	113,718		49.3	%	$	243,383		49.8	%

Gross margins in the AMS segment were 48.9% for the nine months ended March 31, 2013 and 50.3% for the nine months ended March 31, 2012. Gross profit decreased $12.9 million for the nine months ended March 31, 2013 from the nine months ended March 31, 2012 largely due to the reduction in sales. The decrease in gross margin is principally attributable to the reduction in HiRel microelectronics sales, which carried a higher gross margin than the segment average.

Gross margins in the ATS segment were 50.8% for the nine months ended March 31, 2013 and 49.3% for the nine months ended March 31, 2012 due to product mix. The gross margin increased primarily because the increased wireless test product sales carried a higher gross margin than the segment average, combined with the decreased GRMATS sales, which carried a lower gross margin than the segment average. Gross profit decreased $2.1 million for the nine months ended March 31, 2013 from the nine months ended March 31, 2012 largely due to the reduction in sales partially offset by increased margin due to product mix.

Selling, General and Administrative Costs. On a consolidated basis, SG&A costs decreased $3.5 million, or 3%, to $109.8 million for the nine months ended March 31, 2013 from the nine months ended March 31, 2012. Excluding the reserve of $2.5 million in the AMS segment discussion below, SG&A costs decreased $6.0 million, or 5%, to 23.4% of net sales, primarily due to a reduction in various expenses as a result of our implementation of cost saving measures and a reduction in legal fees.

Selling, General and Administrative Costs
Nine Months			% of					% of							% of
Ended			Net					Net							Net
March 31,	AMS		Sales			ATS		Sales			Corporate		Total		Sales
(In thousands, except percentages)

2013	$	40,088		16.8	%	$	57,352		26.1	%	$	12,329	$	109,769		23.9	%
2012	$	40,503		15.7	%	$	60,904		26.4	%	$	11,893	$	113,300		23.2	%

In the AMS segment, SG&A costs decreased $415,000, or 1%, to $40.1 million for the nine months ended March 31, 2013 from the nine months ended March 31, 2012. In March 2013 the Company recorded a reserve of $2.5 million established for accounts receivables with a customer whose bank accounts were seized by the U.S. Attorney. Excluding the reserve of $2.5 million, SG&A costs in the AMS segment decreased $2.9 million, to 15.7% of net sales, due to a combination of reductions in expenses resulting from our implementation of cost saving measures and a reduction in legal fees.

In the ATS segment, SG&A costs decreased $3.6 million, or 6%, to $57.4 million for the nine months ended March 31, 2013 from the nine months ended March 31, 2012. This decrease was primarily attributable to reductions in labor and employee related expenses, largely related to headcount reductions during the second half of fiscal 2012 when the ATS wireless business implemented actions to right size its business.

Research and Development Costs. On a consolidated basis, research and development costs decreased $3.7 million for the nine months ended March 31, 2013 from the nine months ended March 31, 2012.

Research and Development Costs
Nine Months			% of					% of					% of
Ended			Net					Net					Net
March 31,	AMS		Sales			ATS		Sales			Total		Sales
(In thousands, except percentages)

2013	$	27,421		11.5	%	$	37,792		17.2	%	$	65,213		14.2	%
2012	$	27,849		10.8	%	$	41,091		17.8	%	$	68,940		14.1	%

Research and development costs in the ATS segment decreased $3.3 million, primarily due to the reduction of R&D contract engineering headcount in conjunction with the completion of Wireless related development projects near the end of fiscal 2012.

Restructuring Charges. On a consolidated basis, restructuring charges were $3.7 million for the nine months ended March 31, 2013 compared to $5.4 million for the nine months ended March 31, 2012. The restructuring charges were primarily related to cost savings initiatives which resulted in reductions in personnel at various locations worldwide, primarily at our ATS Wireless operations in Europe and Asia.

Impairment of Goodwill and Other Long-Lived Assets. In December 2010, in connection with our consolidation of certain manufacturing operations in our AMS segment, we recorded a $4.9 million impairment charge to restructuring expense based on the then fair value of our Whippany, New Jersey facility. In December 2012, we entered into a contract for the sale of the Whippany building. The net proceeds received in January 2013 were less than the carrying value of the building. Therefore, in December 2012 we recorded a $1.3 million impairment to the asset held for sale. In the third quarter of fiscal 2012, due to a decline in the RFMW reporting unit’s forecasted operating results for the fourth quarter of fiscal 2012 and beyond, we recorded preliminary non-cash impairment charges to both goodwill and tradenames related to the RFMW reporting unit of $56.7 million and $3.0 million, respectively.

ITAR Settlement Expense. In order to resolve a Proposed Charging Letter that references certain outstanding ITAR violations that were disclosed voluntarily to the State Department, we are in the process of finalizing the terms of a Consent Agreement, that would involve, among other things, a fine of $8.0 million payable over a two year period, $4.0 million of which would be suspended and eligible for credit based on qualified compliance expenditures and investments made by the Company. During the quarter ended March 31, 2013, we recorded a charge of $8.0 million representing the legal obligation to the DTCC under the proposed terms of the Consent Agreement. The qualified compliance expenditures are subject to the approval of the DTCC. Going forward, the resolution of this issue will not impact our ability to transact business internationally.

Interest Expense. Interest expense increased by $3.9 million to $29.3 million for the nine months ended March 31, 2013 from $25.4 million for the nine months ended March 31, 2012. Interest expense increased as a result of the 150 basis point increase in our interest rate on May 24, 2012, partially offset by a lower outstanding principal amount due to voluntary debt payments of $80.0 million in the latter half of fiscal 2012 and $35.0 million in the nine months ended March 31, 2013.

Income Taxes. The income tax benefit was $10.5 million for the nine months ended March 31, 2013 on a pre-tax loss of $33.2 million. We recorded an income tax benefit for the nine months ended March 31, 2012 of $8.6 million on a pre-tax loss of $79.5 million. The effective income tax rate for both periods differed from the U.S. statutory rate primarily due to foreign, state and local income taxes, including U.S. income tax on certain foreign net income that we anticipate will be repatriated to the U.S. and, for the nine months ended March 31, 2012, the mostly non-deductible goodwill and intangible impairment charge of $59.7 million.

The income tax benefit for the nine months ended March 31, 2013 reflects a discrete benefit of $442,000 relating to statutory income tax rate reductions in the U.K. and Sweden and the retroactive extension of the U.S. research credit largely offset by an adjustment of estimated deferred taxes. The income tax benefit for the nine months ended March 31, 2012 reflects a discrete benefit of $2.6 million of which $1.6 million relates to previously unanticipated tax benefits taken on our prior year tax returns in the United States and United Kingdom, a $606,000 tax benefit due to a change in reporting for the state of Colorado and a benefit of $700,000 relating to a reduction in the statutory income tax rate in the U.K., partially offset by a prior year non-trade loss in the U.K. of $324,000 for which future utilization is uncertain.

Absent the discrete items, the effective tax rates were 30% and 8% for the nine months ended March 31, 2013 and 2012, respectively. The current year’s provision was a combination of year-to-date U.S. tax benefit on a domestic book loss and foreign tax expense on foreign book income. The prior year’s provision was a combination of U.S. tax benefit on domestic book losses and foreign tax benefit on foreign book losses. The prior year’s effective tax rate was impacted by the aforementioned impairment charge.

In the nine months ended March 31, 2013 and 2012, we paid income taxes of $5.1 million and $7.6 million, and received refunds of $5.7 million and $184,000, respectively, related to federal, state and foreign income taxes.

Net Income (Loss). Net income (loss) was $(22.8) million for the nine months ended March 31, 2013 and $(70.8) million for the nine months ended March 31, 2012.

Liquidity and Capital Resources

As of March 31, 2013, we had $34.8 million of cash and cash equivalents, $260.4 million in working capital and our current ratio was 3.41 to 1, versus $41.3 million, $289.2 million and 3.70 to 1, respectively, at June 30, 2012.

Our principal liquidity requirements are to service our debt and interest and meet our working capital and capital expenditure needs. As of March 31, 2013, we had $606.4 million of debt outstanding, all of which was long-term, under the senior secured term loan. Additionally, at March 31, 2013, we were able to borrow $75.0 million under the revolving portion of our senior secured credit facility, of which none was outstanding.

During the nine months ended March 31, 2013, we had accumulated cash in excess of our forecasted operating needs. Consistent with our objective to reduce the outstanding term loan balance and reduce our ongoing interest expense, we voluntarily prepaid a total of $35.0 million of our term loan during the nine months ended March 31, 2013.

As a result of $118.6 million of payments, including $115.0 million of voluntary prepayments made to date, there are no required debt principal payments due until fiscal 2018.

As of March 31, 2013, we were in compliance with all of the covenants contained in our senior secured credit facility. Certain loan covenants are based on Adjusted EBITDA. Adjusted EBITDA is defined as EBITDA (net income (loss), before interest expense, income taxes, depreciation and amortization) adjusted to add back or subtract certain non-cash, non-recurring and other items, as permitted by various provisions in our senior secured credit facility. Our use of the term Adjusted EBITDA may vary from others in our industry. EBITDA and Adjusted EBITDA are not measures of operating income (loss), performance or liquidity under U.S. GAAP and are subject to important limitations. A reconciliation of net income (loss), which is a U.S. GAAP measure of our operating results, to Adjusted EBITDA, as defined in our senior secured credit facility, is as follows:

	Three Months Ended						Nine Months Ended
	March 31,						March 31,
	2013			2012			2013			2012
	(In thousands)

Net income (loss)	$	(9,389	)	$	(65,261	)	$	(22,783	)	$	(70,838	)
Interest expense		9,448			8,252			29,294			25,386
Provision (benefit) for income taxes		(2,971	)		(5,169	)		(10,453	)		(8,635	)
Depreciation and amortization		20,077			21,059			59,880			62,863
EBITDA		17,165			(41,119	)		55,938			8,776

Restructuring costs and related pro forma savings^(a)		499			5,903			5,083			11,951
Impairment of goodwill and other long-lived assets		-			59,700			1,340			59,700
ITAR settlement expense		8,000			-			8,000			-
Change in fair value of acquisition contingent
consideration liability		-			446			-			1,297
Share-based compensation		1,243			919			2,610			2,649
Special accounts receivable reserve		2,529			-			2,529			-
Write-off of deferred financing costs		-			864			824			864
Other defined items^(b)		9			1,135			943			2,674
Adjusted EBITDA	$	29,445		$	27,848		$	77,267		$	87,911

^(a)

Primarily reflects costs associated with the reorganization of our European operations and consolidation of certain of our U.S. component facilities. Pro forma savings reflect the costs that we estimate would have been eliminated during the fiscal year in which a restructuring occurred had the restructuring occurred as of the first day of that fiscal year. Pro forma savings were estimated to be $103,000 and $1.4 million for the three and nine months ended March 31, 2013. The pro forma savings of $1.9 million and $6.6 million for the three and nine months ended March 31, 2012 were not fully reflected in our Adjusted EBITDA as reported in our March 31, 2012 report on Form 10-Q as they relate to restructuring activities recorded throughout fiscal 2012.

^(b)

Reflects other adjustments required in calculating our debt covenant compliance. These other defined items include legal fees related to certain litigation and business acquisition and divestiture related costs.

Financial covenants in our senior secured credit facility include a maximum leverage ratio of total debt (less up to $15.0 million of unrestricted cash) to Adjusted EBITDA, as defined in our senior secured credit facility. The maximum leverage ratio permitted for the twelve months ended March 31, 2013 was 5.50, whereas our actual leverage ratio was 4.89. The maximum leverage ratio permitted periodically decreases as follows:

Effective as of	Maximum
the Twelve Months	Permitted
Ending	Leverage Ratio

September 30, 2013		5.25
March 31, 2014		5.00
June 30, 2014		4.50
September 30, 2014		4.00
December 31, 2014		3.75
March 31, 2015		3.50

Our senior secured credit facility contains restrictions on our activities, including but not limited to covenants that restrict us and our restricted subsidiaries, as defined in our senior secured credit facility, from:

incurring additional indebtedness and issuing disqualified stock or preferred stock;

making certain investments or other restricted payments;

paying dividends and making other distributions with respect to capital stock, or repurchasing, redeeming or retiring capital stock or subordinated debt;

selling or otherwise disposing of assets;

under certain circumstances, issuing or selling equity interests;

creating liens on our assets;

consolidating or merging with, or acquiring in excess of specified annual limitations, another business, or selling or disposing of all or substantially all of our assets; and

entering into certain transactions with our affiliates.

If for any reason we fail to comply with the covenants in the senior secured credit facility, we would be in default under the terms of the agreement governing our outstanding debt. If such a default were to occur, the lenders under the senior secured credit facility could elect to declare all amounts outstanding thereunder immediately due and payable, and the lenders would not be obligated to continue to advance funds to us. If the amounts outstanding under these debt agreements are accelerated, our assets may not be sufficient to repay in full the amounts owed.

We expect that cash generated from operating activities and availability under the revolving portion of our new senior secured credit facility will be our principal sources of liquidity. Our ability to make payments on and to refinance our indebtedness and to fund working capital needs and planned capital expenditures will depend on our ability to generate cash in the future. This, to a certain extent, is subject to general economic, financial, competitive and other factors that are beyond our control. In addition, to the extent we have consolidated excess cash flows, as defined in the credit agreement governing the senior secured credit facility, we must use specified portions of the excess cash flows to prepay the senior secured credit facility.

Based on our current level of operations, we believe our cash flow from operations and available borrowings under our senior secured credit facility will be adequate to meet our liquidity needs for at least the next twelve months. We cannot assure you, however, that our business will generate sufficient cash flow from operations, or that future borrowings will be available in an amount sufficient to enable us to repay our indebtedness at maturity or to fund other liquidity needs. We may need to refinance all or a portion of our indebtedness on or before the maturity thereof. We cannot assure you that we will be able to refinance any of our indebtedness on commercially reasonable terms or at all.

Cash Flows

For the nine months ended March 31, 2013, our cash flow provided by operations was $43.1 million. Our investing activities used cash of $12.2 million, primarily for capital expenditures of $14.3 million partially offset by proceeds of $1.6 million from the sale of our Whippany, New Jersey facility. Our financing activities used cash of $35.6 million, primarily for voluntary debt prepayments.

For the nine months ended March 31, 2012, our cash flow provided by operations was $55.0 million. Our investing activities used cash of $19.9 million, primarily for capital expenditures of $15.0 million and earn-out payments of $5.1 million related to a prior year acquisition. Our financing activities used cash of $69.7 million, primarily for debt repayments of $68.6 million and for the payment of contingent consideration related to a business acquisition of $948,000.

Capital Expenditures

Capital expenditures were $14.3 million and $15.0 million for the nine months ended March 31, 2013 and 2012, respectively. Our capital expenditures primarily consist of equipment replacements.

Contractual Obligations

There have been no material changes in our contractual obligations as disclosed in our fiscal 2012 Form 10-K.

Off-Balance Sheet Arrangements

We do not maintain any off-balance sheet arrangements, transactions, obligations or other relationships with unconsolidated entities that would be expected to have a material current or future effect upon our results of operations or financial condition.

Critical Accounting Policies and Estimates

Information regarding our critical accounting policies and estimates appears within the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our fiscal 2012 Form 10-K. During the nine month period ended March 31, 2013, there were no significant changes to any critical accounting policies or to the related estimates and judgments involved in applying those policies.

Recent Accounting Pronouncements

For information with respect to recent accounting pronouncements and the impact of these pronouncements on our consolidated financial statements, see Note 1 of Notes to Unaudited Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk. We are subject to interest rate risk in connection with borrowings under our senior secured credit facility. We currently do not have interest rate swap agreements hedging this debt. As of March 31, 2013, there was $606.4 million outstanding at adjusted LIBOR plus 4.5% under the term-loan portion of the senior secured credit facility, all of which is subject to variable interest rates. The adjusted LIBOR, as defined in the senior secured credit facility, has a floor of 1.25% on the term loan. Based on LIBOR at March 31, 2013, an increase of 1% in interest rates would result in a 0.03% increase, due to the 1.25% floor, or a $184,000 increase in our annual interest expense. Any 1% increase in interest rates above the 1.25% floor would result in a $6.1 million increase in our annual interest expense. A 1% change in interest rates would result in a $760,000 change in our annual interest expense on the revolving loan borrowings, assuming the entire $75.0 million was outstanding. Any debt we incur in the future may also bear interest at floating rates.

Foreign Currency Risk. Foreign currency contracts are used to protect us from exchange rate fluctuation from the time customers are invoiced in local currency until such currency is exchanged for U.S. dollars. We periodically enter into foreign currency contracts, which are not designated as hedges, and the change in the fair value is included in income currently within other income (expense). As of March 31, 2013, we had $38.5 million of notional value foreign currency forward contracts maturing through April 30, 2013. Notional amounts do not quantify risk or represent assets or liabilities, but are used in the calculation of cash settlements under the contracts. The fair value of these contracts at March 31, 2013 was an asset of $184,000. If foreign currency exchange rates (primarily the British pound and the Euro) change by 10% from the levels at March 31, 2013, the effect on our comprehensive income would be approximately $18.4 million.

Inflation Risk. Inflation has not had a material impact on our results of operations or financial condition during the preceding three years.

ITEM 4.

CONTROLS AND PROCEDURES

Our disclosure controls and procedures under the Securities Exchange Act of 1934, as amended, are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the Securities and Exchange Commission. Our disclosure controls and procedures are also designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. Our Principal Executive Officer and our Principal Financial Officer, with the assistance from other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of March 31, 2013 and, based on their evaluation, have concluded that the disclosure controls and procedures were effective as of such date.

There have been no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

Item 1A.

Risk Factors

There have been no material changes in our risk factors disclosed in our fiscal 2012 Form 10-K.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

None

Item 3.

Defaults upon Senior Securities

None

Item 4.

Mine Safety Disclosures

Not applicable

Item 5.

Other Information

None

Item 6.

Exhibits

Exhibit No.		Exhibit Description
31.1		Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Chief Executive Officer)

31.2		Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Chief Financial Officer)

31.3		Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Principal Accounting Officer)

32.1		Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Chief Executive Officer)

32.2		Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Chief Financial Officer)

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	AEROFLEX HOLDING CORP.

	/s/ John Adamovich, Jr.
	John Adamovich, Jr.
	Senior Vice President and
	Chief Financial Officer
	(Principal Financial Officer)

May 9, 2013

EXHIBIT INDEX

Exhibit No.		Exhibit Description
31.1		Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Chief Executive Officer)

31.2		Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Chief Financial Officer)

31.3		Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Principal Accounting Officer)

32.1		Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Chief Executive Officer)

32.2		Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Chief Financial Officer)

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document